Pomerantz LLP Investigates Claims of Securities Fraud Against Humana Inc.

Pomerantz LLP, a renowned firm in corporate, securities, and antitrust class litigation, is investigating claims of securities fraud against Humana Inc. The investigation concerns whether Humana and its officers or directors have engaged in unlawful business practices, particularly regarding the payment of illegal kickbacks to Medicare Advantage plan brokers. This development follows a False Claims Act complaint filed by the U.S. Department of Justice, which alleged that Humana and other health insurance companies paid hundreds of millions of dollars in kickbacks between 2016 and 2021. As a result, Humana's stock price plummeted by 2.36% to $256.04 per share on May 1, 2025.

Key Takeaways:

• Pomerantz LLP is investigating claims of securities fraud against Humana Inc. on behalf of investors.
• The investigation centers around the alleged payment of hundreds of millions of dollars in illegal kickbacks to Medicare Advantage plan brokers between 2016 and 2021.
• The False Claims Act complaint was filed by the U.S. Department of Justice, which led to a 2.36% drop in Humana's stock price to $256.04 per share on May 1, 2025.
• Pomerantz LLP has a long history of fighting for the rights of victims of securities fraud, breaches of fiduciary duty, and corporate misconduct, dating back to the firm's founding by Abraham L. Pomerantz.
• The firm has recovered numerous multimillion-dollar damages awards on behalf of class members.

Statistics:

• Humana's stock price fell by $6.20 per share on May 1, 2025, following the announcement of the DOJ's lawsuit.
• The U.S. Department of Justice alleged that Humana and other health insurance companies paid hundreds of millions of dollars in illegal kickbacks to Medicare Advantage plan brokers between 2016 and 2021.
• Pomerantz LLP has over 85 years of experience in corporate, securities, and antitrust class litigation.

Sources:

• Pomerantz LLP, New York, Chicago, Los Angeles, London, Paris, and Tel Aviv office locations
• U.S. Department of Justice, False Claims Act complaint
• Humana Inc., NYSE: HUM, stock price

- Source: Pomerantz LLP

Investigation Concerning Securities Fraud Against Humana Inc.